|
ALZN
|
Alzamend Neuro, Inc.
|
US
|
NASDAQ
|
|
AMGN
|
Amgen Inc.
|
US
|
NASDAQ
|
|
ATHE
|
Alterity Therapeutics Limited
|
US
|
NASDAQ
|
|
AVXL
|
Anavex Life Sciences Corp.
|
US
|
NASDAQ
|
|
AZN
|
Astrazeneca PLC
|
US
|
NASDAQ
|
|
BHVN
|
Biohaven Pharmaceutical Holding Company Ltd.
|
US
|
NYSE
|
|
BTAI
|
BioXcel Therapeutics, Inc.
|
US
|
NASDAQ
|
|
BWAY
|
Brainsway Ltd.
|
US
|
NASDAQ
|
|
CCCC
|
C4 Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CERE
|
Cerevel Therapeutics Holdings, Inc.
|
US
|
NASDAQ
|
|
CING
|
Cingulate Inc.
|
US
|
NASDAQ
|
|
CYTK
|
Cytokinetics, Incorporated
|
US
|
NASDAQ
|
|
DNLI
|
Denali Therapeutics Inc.
|
US
|
NASDAQ
|
|
ELYM
|
Eliem Therapeutics, Inc
|
US
|
NASDAQ
|
|
GBNH
|
Greenbrook TMS Inc.
|
US
|
NASDAQ
|
|
HBIO
|
Harvard Bioscience, Inc.
|
US
|
NASDAQ
|
|
IBRN
|
iShares Neuroscience and Healthcare ETF
|
US
|
AMEX
|
|
IMRX
|
Immuneering Corporation
|
US
|
NASDAQ
|
|
ITCI
|
Intra-Cellular Therapies Inc.
|
US
|
NASDAQ
|
|
ITGR
|
Integer Holdings Corporation
|
US
|
NYSE
|